RESEARCH TRIANGLE PARK, N.C. – Marken will double the space of its GMP facility in Frankfurt to further expand its frozen room storage capabilities in anticipation of the COVID-19 vaccine and storage needs.
“Cell and gene therapies are a strategic focus for Marken due to their high complexity and the exacting quality standards they require, both in transport and storage,” said Marken president Ariette van Strien.
“In addition to the growing need for cryogenic storage, Marken’s expansion of the Frankfurt facility is driven by the high demand to provide up to -80C storage for future vaccines and treatments.”
Marken’s expansion of its facilities in Frankfurt will add an additional 16,000 square feet of space, increasing total available space for client materials to over 40,000 square feet. This additional space is expected to be fully operational by October, 2020.
In addition, Marken’s cryogenic storage services went live in June in both Frankfurt and Philadelphia. These latest additions to the Marken GMP network service portfolio further reinforces the company’s dedication to serving its clients as a complete, end-to-end service provider. Future cryogenic storage locations will include the APAC region.
Marken is a wholly owned subsidiary of the UPS Healthcare division. With Polar Speed and Marken included, the UPS division staffs 128 locations with 5,500 employees worldwide.